Truveta Inc.

Truveta is a health technology company that operates a data and analytics platform designed to accelerate medical research and improve patient care. Founded in 2020, its mission is "Saving Lives with Data" by providing a comprehensive, de-identified dataset of electronic health records (EHR). The company is headquartered in Bellevue, Washington.

The company's core offerings include Truveta Data, which aggregates de-identified EHR data from a growing collective of over 30 U.S. health systems, representing more than 130 million patients and approximately 18% of daily clinical care in the United States. This dataset, refreshed daily, includes clinical notes, medical images, genomics, social determinants of health (SDOH), mortality, and claims data. Truveta also offers Truveta Studio, a research environment with analytics tools, and Truveta Intelligence, an AI-powered solution that provides real-time insights from its vast dataset through natural language queries. These products and services cater to life science organizations, public health entities, healthcare providers, and academic researchers.

In recent news, Truveta launched its AI-powered Truveta Intelligence tool in April 2026, aiming to deliver real-time clinical insights and significantly shorten research timelines. The company also held its Truveta Symposium 2026, emphasizing collaboration across health systems and life sciences to translate healthcare data into actionable insights. Truveta is privately held and has raised $515 million in funding to date, with a valuation exceeding $1 billion as of January 2025. Terry Myerson serves as the CEO and co-founder, and Robin Damschroder was appointed Chair of the Board of Directors in March 2026.